What are you looking for?

MINIRIN MELT 60mcg Orally Lyophilisate Tablet 30’s

1,499.34 Original price was: ₹1,499.34.1,307.72Current price is: ₹1,307.72.
In Stock

MINIRIN MELT 60mcg Orally Lyophilisate Tablet is a synthetic medication that mimics the natural hormone vasopressin (antidiuretic hormone) in the body. It works mainly by reducing the amount of urine produced by the kidneys, helping the body retain water and maintain proper fluid balance. It is commonly used to treat conditions such as central diabetes insipidus, bedwetting (nocturnal enuresis), and frequent nighttime urination (nocturia), and in some cases, mild bleeding disorders like hemophilia A and von Willebrand disease type 1. Because it affects water balance, it must be used carefully to avoid low sodium levels and fluid overload.

In Stock
Add to wishlist

Description

MINIRIN MELT 60mcg Orally Lyophilisate Tablet is a synthetic analogue of the naturally occurring human hormone vasopressin (also known as antidiuretic hormone or adh). it is designed to act primarily on the kidneys to reduce urine production and help the body retain water. unlike vasopressin, MINIRIN MELT 60mcg Orally Lyophilisate Tablet has a stronger and more selective action on v2 receptors, which are responsible for regulating water balance, and a much weaker effect on v1 receptors, which are associated with blood vessel constriction. this selectivity makes it clinically useful and reduces some of the cardiovascular side effects seen with natural vasopressin.

MINIRIN MELT 60mcg Orally Lyophilisate Tablet works by increasing water reabsorption in the renal collecting ducts. it stimulates v2 receptors in the kidney, which activates a cascade involving cyclic amp (camp). this leads to the insertion of aquaporin-2 water channels into the apical membrane of collecting duct cells. as a result, more water is reabsorbed back into the bloodstream, and urine becomes more concentrated and reduced in volume. this mechanism helps restore fluid balance in conditions where the body either cannot produce enough adh or needs temporary control of excessive urination.

clinically, MINIRIN MELT 60mcg Orally Lyophilisate Tablet is widely used in conditions such as central diabetes insipidus, nocturnal enuresis (bedwetting), and nocturia due to nocturnal polyuria. it is also used in certain bleeding disorders like mild hemophilia a and type 1 von willebrand disease because it can increase levels of clotting factors viii and von willebrand factor. its ability to act on both renal water regulation and hemostasis makes it a versatile medication in specialized medical settings. however, it must be used carefully due to the risk of water retention and electrolyte imbalance.

because MINIRIN MELT 60mcg Orally Lyophilisate Tablet directly affects water balance, its clinical use requires careful monitoring of fluid intake and serum sodium levels. excess water retention can lead to hyponatremia, a potentially serious condition where sodium levels in the blood become dangerously low. despite this risk, when used appropriately under medical supervision, MINIRIN MELT 60mcg Orally Lyophilisate Tablet significantly improves quality of life for patients with chronic conditions involving excessive urination or mild bleeding tendencies.

ingredients

  • MINIRIN MELT 60mcg Orally Lyophilisate Tablet acetate: the active pharmaceutical ingredient (api) responsible for mimicking the action of antidiuretic hormone. it acts on renal v2 receptors to reduce urine output and increase water reabsorption in the kidneys.
  • chlorobutanol (in some formulations): a preservative used in certain injectable or nasal preparations to maintain product stability and prevent microbial contamination.
  • sodium chloride: may be present in injectable formulations to maintain isotonicity, ensuring compatibility with body fluids and reducing irritation.
  • purified water: used as a solvent in liquid formulations such as nasal sprays and injections, ensuring proper drug delivery.
  • other excipients: depending on the dosage form (tablet, nasal spray, or injection), additional stabilizers, buffers, or flavoring agents may be included to enhance shelf life, absorption, and patient compliance.

key uses

  • central diabetes insipidus: used to replace deficient antidiuretic hormone in patients who are unable to produce sufficient natural adh, helping reduce excessive urination and extreme thirst.
  • nocturnal enuresis (bedwetting): helps children and sometimes adults control nighttime urination by reducing urine production during sleep.
  • nocturia due to nocturnal polyuria: reduces the need for frequent nighttime urination in adults, improving sleep quality and reducing fatigue.
  • hemophilia a (mild cases): temporarily increases factor viii levels in the blood to support clotting in patients with mild hemophilia a.
  • von willebrand disease type 1: stimulates release of von willebrand factor, improving platelet adhesion and reducing bleeding episodes in selected patients.
  • diagnostic testing: sometimes used in controlled settings to assess kidney concentrating ability or differentiate types of diabetes insipidus.

how to use

MINIRIN MELT 60mcg Orally Lyophilisate Tablet is available in multiple formulations, including oral tablets, nasal sprays, and injectable forms. the choice of formulation depends on the medical condition being treated and patient-specific factors such as age, severity of symptoms, and response to therapy. it is usually taken at a consistent time each day or night as prescribed by a healthcare provider. for conditions like nocturnal enuresis or nocturia, it is often administered in the evening to reduce nighttime urine production.

patients are typically advised to limit fluid intake during treatment to reduce the risk of water retention and low sodium levels. this is especially important in the hours surrounding administration. the medication should be used exactly as directed by a healthcare professional, and switching between formulations should only be done under medical supervision because absorption and potency can vary between nasal, oral, and injectable forms.

regular monitoring may be required in long-term use, particularly for sodium levels and overall fluid balance. patients should be educated to recognize early signs of water overload or hyponatremia, such as headache, nausea, confusion, or unusual weight gain, and seek medical attention if these occur.

safety information

  • warnings: MINIRIN MELT 60mcg Orally Lyophilisate Tablet can cause water retention and hyponatremia, which may lead to serious neurological complications including seizures in severe cases. fluid restriction is often necessary during treatment to minimize this risk. careful monitoring of serum sodium levels is recommended in at-risk individuals.
  • side effects: common side effects include headache, nausea, mild abdominal discomfort, nasal irritation (with nasal spray), and flushing. serious side effects may include severe hyponatremia, confusion, seizures, or reduced consciousness due to water intoxication.
  • precautions: it should be used with caution in patients with kidney impairment, cardiovascular disease, or conditions associated with fluid imbalance. elderly patients are at higher risk of developing hyponatremia and require closer monitoring.
  • pregnancy/breastfeeding: MINIRIN MELT 60mcg Orally Lyophilisate Tablet is generally considered relatively safe when clearly needed, but should only be used under strict medical supervision during pregnancy or lactation. limited amounts may pass into breast milk, but clinically significant effects are uncommon.
  • interactions: drugs that increase the risk of hyponatremia, such as selective serotonin reuptake inhibitors (ssris), tricyclic antidepressants, carbamazepine, nsaids, and certain diuretics, may enhance the risk of water retention. alcohol may also interfere with fluid balance and should be avoided or limited.

additional information

  • storage: store at room temperature away from direct sunlight, moisture, and heat. nasal sprays should be kept upright and protected from contamination. do not freeze liquid formulations.
  • missed dose: if a dose is missed, it should be taken as soon as remembered unless it is close to the next scheduled dose. in that case, the missed dose should be skipped to avoid doubling. patients should not take extra doses to compensate.
  • overdose: overdose may lead to excessive water retention and severe hyponatremia, presenting as headache, nausea, confusion, seizures, or swelling. immediate medical attention is required, and treatment may include fluid restriction and correction of sodium imbalance under hospital care.
  • habit forming: MINIRIN MELT 60mcg Orally Lyophilisate Tablet is not considered habit-forming or addictive. however, improper use or overuse can lead to dangerous fluid imbalance and medical complications, making adherence to prescribed guidelines essential.

frequently asked questions

Q: what is MINIRIN MELT 60mcg Orally Lyophilisate Tablet mainly used for?

A: MINIRIN MELT 60mcg Orally Lyophilisate Tablet is mainly used to treat conditions related to excessive urination such as central diabetes insipidus, nocturnal enuresis (bedwetting), and nocturia. it is also used in certain bleeding disorders like mild hemophilia a and von willebrand disease type 1 to help improve clotting factor levels.

Q: can MINIRIN MELT 60mcg Orally Lyophilisate Tablet be used long term?

A: yes, MINIRIN MELT 60mcg Orally Lyophilisate Tablet can be used long term under medical supervision, especially in chronic conditions like diabetes insipidus. however, regular monitoring of sodium levels and fluid balance is essential to prevent complications such as hyponatremia.

Q: what are the most important safety concerns with MINIRIN MELT 60mcg Orally Lyophilisate Tablet?

A: the most important safety concern is the risk of hyponatremia (low sodium levels) due to water retention. this can lead to symptoms like headache, nausea, confusion, and in severe cases, seizures. fluid restriction and monitoring are important during treatment.

Q: who should avoid MINIRIN MELT 60mcg Orally Lyophilisate Tablet?

A: individuals with severe kidney disease, low sodium levels, or a history of hyponatremia should generally avoid MINIRIN MELT 60mcg Orally Lyophilisate Tablet unless specifically advised by a healthcare provider. it should also be used cautiously in elderly patients.

Q: does MINIRIN MELT 60mcg Orally Lyophilisate Tablet affect blood pressure?

A: MINIRIN MELT 60mcg Orally Lyophilisate Tablet has minimal direct effect on blood pressure because it has weak activity on vascular receptors. however, fluid retention in sensitive individuals may indirectly influence cardiovascular status, which is why monitoring is important.

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.

Certified Content
Medical Disclaimer:
At Gem Pharmacy, we make every effort to provide accurate, expert-written, and thoroughly reviewed information related to medicines. However, this information should not be considered a substitute for professional medical advice, diagnosis, or treatment from a qualified doctor.

The purpose of this information is to educate users and improve communication between patients and healthcare professionals. It should not be used to diagnose or treat any condition.

Always consult a certified healthcare professional before taking any medication.
Written by
Palak
Palak
D Pharma
Reviewed by
Palak 2
Palak
D Pharma

No products in the cart.